Skip to main content
. 2022 May 16;13:882647. doi: 10.3389/fmicb.2022.882647

Table 2.

The resistance of NTS isolates from diarrheal children in 2014–2019.

Antimicrobial class Antimicrobial agents No. of strains (N/%)
Resistant (R) Intermediate (I) Susceptible (S)
Penicillins Ampicillin (AMP) 207 79.6 1 0.4 52 20.0
β-lactam combination agents Ampicillin-sulbactam (AMS) 124 47.7 78 30.0 58 22.3
Cephems Cefotaxime (CTX) 37 14.2 4 1.5 219 84.2
Ceftazidime (CAZ) 7 2.7 6 2.4 247 95.0
Cefoxitin (CFX) 2 0.8 10 3.8 248 95.4
Cefazolin (CFZ) 119 45.8 76 29.2 119 45.8
Sulfonamides Trimethoprim-sulfamethoxazole (SXT) 66 25.4 - - 194 74.6
Aminoglycosides Gentamicin (GEN) 27 10.4 7 2.7 226 86.9
Quinolones Nalidixic acid (NAL) 158 60.8 - - 102 39.2
Ciprofloxacin (CIP) 32 12.3 159 61.2 69 26.5
Phenicols Chloramphenicol (CHL) 46 17.7 9 3.5 205 78.8
Carbapenems Imipenem (IMP) 0 0 2 0.8 258 99.2
Tetracyclines Tetracyclines (TET) 158 60.8 11 4.2 91 35.0
Macrolides Azithromycin (AZM) 25 9.6 _ _ 235 90.4
Pansusceptible 5 1.9
≥1 antimicrobial class 255 98.1
MDR ≥3 antimicrobial class 203 78.1
≥5 antimicrobial class 58 22.3
≥7 antimicrobial class 14 5.4